July 15 (Reuters) - Bravura Solutions Ltd (BVS) :
- UPGRADING ITS FY24 UNAUDITED EBITDA GUIDANCE TO A$25 MILLION
- CASH EBITDA GUIDANCE OF AROUND A$10M FOR FY24
(([email protected];))
- Forums
- ASX - By Stock
- BVS
- News: BVS Bravura Solutions Upgrades Its FY24 Unaudited EBITDA Guidance To A$25 Mln
News: BVS Bravura Solutions Upgrades Its FY24 Unaudited EBITDA Guidance To A$25 Mln
Featured News
Add BVS (ASX) to my watchlist
|
|||||
Last
$1.11 |
Change
0.040(3.74%) |
Mkt cap ! $497.6M |
Open | High | Low | Value | Volume |
$1.25 | $1.30 | $1.09 | $8.031M | 6.980M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 898 | $1.11 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.13 | 7242 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 898 | 1.110 |
2 | 23000 | 1.100 |
3 | 12976 | 1.090 |
3 | 34416 | 1.085 |
3 | 33905 | 1.080 |
Price($) | Vol. | No. |
---|---|---|
1.125 | 7242 | 2 |
1.130 | 3982 | 1 |
1.135 | 5612 | 2 |
1.140 | 3982 | 1 |
1.145 | 10982 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
BVS (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online